Scarica l'app Stockscreener
11.04
2.13%
0.23
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$10.81
Aprire:
$11.02
Volume 24 ore:
9,134
Relative Volume:
0.31
Capitalizzazione di mercato:
$70.17M
Reddito:
-
Utile/perdita netta:
$-61.23M
Rapporto P/E:
-0.8166
EPS:
-13.5194
Flusso di cassa netto:
$22.49M
1 W Prestazione:
-7.85%
1M Prestazione:
-12.17%
6M Prestazione:
-38.80%
1 anno Prestazione:
-13.62%
Intervallo 1D:
$10.90
$11.41
Intervallo di 1 settimana:
$10.56
$11.94
Portata 52W:
$10.56
$19.93
Assembly Biosciences Inc Stock (ASMB) Company Profile
Nome
Assembly Biosciences Inc
Settore
Industria
Telefono
(833) 409-4583
Indirizzo
TWO TOWER PLACE, SOUTH SAN FRANCISCO
Confronta ASMB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ASMB
Assembly Biosciences Inc
|
11.04 | 70.17M | 0 | -61.23M | 22.49M | -13.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
495.42 | 127.22B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
689.50 | 75.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.45 | 35.94B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.43 | 31.38B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.84 | 26.84B | 3.32B | -860.46M | -1.04B | -8.32 |
Assembly Biosciences Inc Stock (ASMB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-20 | Aggiornamento | Jefferies | Hold → Buy |
| 2021-09-13 | Iniziato | H.C. Wainwright | Neutral |
| 2021-09-02 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-03-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-11-06 | Downgrade | Jefferies | Buy → Hold |
| 2020-10-19 | Iniziato | Truist | Buy |
| 2019-10-16 | Iniziato | Mizuho | Buy |
| 2018-11-19 | Iniziato | Leerink Partners | Outperform |
| 2018-10-08 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2018-08-08 | Iniziato | Robert W. Baird | Outperform |
| 2018-04-13 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2018-01-05 | Iniziato | B. Riley FBR, Inc. | Neutral |
| 2017-11-08 | Iniziato | Jefferies | Buy |
| 2017-05-30 | Iniziato | Chardan Capital Markets | Buy |
Mostra tutto
Assembly Biosciences Inc Borsa (ASMB) Ultime notizie
ASMB stock touches 52-week low at $10.8 amid market challenges - Investing.com
Assembly Biosciences, Inc. (NASDAQ:ASMB) Short Interest Update - Defense World
Is Assembly Biosciences, Inc. (ASMB) Among Stocks With At Least $20 Million In Insider Spending Recently? - Insider Monkey
10 Stocks With At Least $20 Million In Insider Spending Recently - Insider Monkey
ASMB stock touches 52-week low at $11.44 amid market challenges - Investing.com India
ASMB stock touches 52-week low at $11.44 amid market challenges By Investing.com - Investing.com South Africa
(ASMB) Trading Report - Stock Traders Daily
Assembly Biosciences and Gilead's genital herpes treatment gives positive results in early stage trial - MSN
Assembly Biosciences Doses First Subject in Phase 1a Trial of Hepatitis Delta Virus Therapy Candidate; Shares Up - Marketscreener.com
Assembly Biosciences Initiates Phase 1a Study Of ABI-6250, Oral Entry Inhibitor For - Nasdaq
Assembly Biosciences initiates phase 1a trial for HDV treatment candidate By Investing.com - Investing.com South Africa
Assembly Biosciences initiates phase 1a trial for HDV treatment candidate - Investing.com India
Assembly Biosciences Doses First Participant in Phase 1a Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus - The Manila Times
Infectious disease index recovers from -25% low, ends 2024 down 6.28% - BioWorld Online
(ASMB) Investment Analysis - Stock Traders Daily
Assembly Bio advances herpes treatment into next trial phase By Investing.com - Investing.com Nigeria
Assembly Bio advances herpes treatment into next trial phase - Investing.com
Catalent Appoints Susan Mahony, Marie-France Tschudin and Tim Walbert to its Board of Directors - citybiz
Catalent Announces New Board Appointments - Business Wire
Assembly Biosciences Reports Positive Interim Phase 1a Results from Clinical Trial Evaluating Long-Acting Helicase-Primase Inhibitor ABI-1179 in Development for Recurrent Genital Herpes - The Manila Times
Can This New Once-Weekly Herpes Treatment Transform Patient Care? Phase 1a Results Reveal Breakthrough - StockTitan
Peapod Lane Capital LLC Takes $994,000 Position in Assembly Biosciences, Inc. (NASDAQ:ASMB) - MarketBeat
Biotechnology Market Size, Share, Trends Research Report 2025-2034 - PharmiWeb.com
JPMorgan Chase & Co. Boosts Holdings in Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
Reviewing Assembly Biosciences (NASDAQ:ASMB) and CytoDyn (OTCMKTS:CYDY) - Defense World
When the Price of (ASMB) Talks, People Listen - Stock Traders Daily
AC Immune (NASDAQ:ACIU) & Assembly Biosciences (NASDAQ:ASMB) Head-To-Head Review - Defense World
(ASMB) Technical Pivots with Risk Controls - Stock Traders Daily
Geode Capital Management LLC Has $712,000 Stock Position in Assembly Biosciences, Inc. (NASDAQ:ASMB) - Defense World
Gilead raises Assembly Bio stake to ~30% - MSN
IGM Bio stock plunges as analysts downgrade (IGMS:NASDAQ) - Seeking Alpha
ABI-4334 shows promise in hepatitis B Phase 1b trial: Data - Liver Disease News
Trend Tracker for (ASMB) - Stock Traders Daily
Assembly Biosciences (NASDAQ:ASMB) Share Price Passes Above 200 Day Moving AverageHere's What Happened - MarketBeat
Assembly Biosciences extends lease through 2029 By Investing.com - Investing.com Nigeria
Assembly Biosciences extends lease through 2029 - Investing.com India
Brokerages Set TKO Group Holdings, Inc. (NYSE:TKO) PT at $136.79 - Defense World
Jefferies Top 2025 Stock Picks Include 5 Sizzling Large Cap Dividend Blue Chips - 24/7 Wall St.
Hedge Fund and Insider Trading News: Glenn Greenberg, Warren Buffett, Bill Ackman, D.E. Shaw, Millennium Management, Assembly Biosciences Inc (ASMB), Simon Property Group Inc (SPG), and More - Insider Monkey
Financial Analysis: Assembly Biosciences (NASDAQ:ASMB) vs. LifeVantage (NASDAQ:LFVN) - Defense World
Assembly Biosciences director Houghton buys $49,997 in stock By Investing.com - Investing.com Australia
Assembly Biosciences director Houghton buys $49,997 in stock - Investing.com India
Assembly Biosciences, Inc. (NASDAQ:ASMB) Director Acquires $49,983.22 in Stock - MarketBeat
Gilead Buys $20.1 Million of Assembly Biosciences Stock - MSN
Assembly Biosciences, Inc. (NASDAQ:ASMB) Sees Large Drop in Short Interest - MarketBeat
(ASMB) Long Term Investment Analysis - Stock Traders Daily
Assembly Biosciences Inc Azioni (ASMB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):